Samsung Bioepis Moves Forward With Soliris Rival

Completes Phase III Trial For SB12 Proposed Eculizumab Biosimilar

 
• By David Wallace
  
Eculizumab mab word pink
Samsung Bioepis has completed its Phase III trial for eculizumab • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products